Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sartorius Stedim Biotech Unaudited Results For First Nine Months Of 2025

Oct 16 (Reuters) - Sartorius Stedim Biotech SA STDM.PA:

SARTORIUS STEDIM BIOTECH PUBLISHES UNAUDITED RESULTS FOR THE FIRST NINE MONTHS OF 2025

UNDERLYING EBITDA INCREASES 21.0% TO 683 MILLION EUROS; MARGIN 31.1%

SALES REVENUE REACHES 2,195 MILLION EUROS, UP 10.2% IN CONSTANT CURRENCIES

9M UNDERLYING NET PROFIT UP 34.3% TO 320 MILLION EUROS

OUTLOOK: MANAGEMENT SHARPENS FULL-YEAR GUIDANCE AT UPPER END OF RANGE

Source text: nEQ4npcyga

Further company coverage: STDM.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Sartorius Stedim Biotech SA

See all news